Zobrazeno 1 - 10
of 14
pro vyhledávání: '"A. F. D. Di Stefano"'
Autor:
A. F. D. Di Stefano, M. M. Radicioni, A. Vaccani, G. Caccia, F. Focanti, E. Salvatori, F. Pelacchi, R. Picollo, M. T. Rosignoli, S. Olivieri, G. Bovi, A. Comandini
Publikováno v:
Infectious Diseases in Obstetrics and Gynecology, Vol 2020 (2020)
Purpose. A novel fixed-dose combination of 150 mg of econazole with 6 mg of benzydamine formulated in vaginal ovules was investigated in a randomised, double-blind, four-parallel group, tolerability, and pharmacokinetic Phase I study in healthy women
Externí odkaz:
https://doaj.org/article/3c1c68baad9749f29151aebdaa2ba5fa
Autor:
Andrea F. D. Di Stefano, Milko M. Radicioni, Francesca Morano, Alessandra Gentili, Elena Mallat, Dario Cuomo, Tonia Mazzarella, Veronica Di Fonzo
Publikováno v:
Antibiotics; Volume 11; Issue 11; Pages: 1458
The present Phase I study investigated, for the first time, fosfomycin pharmacokinetics in humans after two 3 g doses of fosfomycin trometamol administered 27 h apart, according to the dose regimen recommended for the prophylactic indication for tran
Autor:
Angelo Vaccani, Alessandro Mazzetti, Milko Radicioni, Andrea F. D. Di Stefano, Luigi Maria Longo, Luigi Moro
Publikováno v:
Antibiotics, Vol 10, Iss 167, p 167 (2021)
Antibiotics
Volume 10
Issue 2
Antibiotics
Volume 10
Issue 2
The primary objective of this single- and multiple-dose pharmacokinetic study was the investigation of rifamycin SV’s pharmacokinetic profile in plasma and urine. All the 18 enrolled healthy men and post-menopausal women received modified release t
Publikováno v:
Advances in Therapy
Introduction Few studies have evaluated whether the pharmacokinetics of N-acetyl-cysteine (NAC) are different in Chinese and Caucasian individuals. Methods This single- and multiple-dose, single-centre, open-label, phase I clinical study was conducte
Autor:
Giorgio Caccia, Enrica Salvatori, Andrea Vele, Milko M. Radicioni, Anna Mancarella Eberhardt, Francesca Focanti, Andrea F. D. Di Stefano
Publikováno v:
Open Journal of Obstetrics and Gynecology. :130-138
Background and Aims: A gynaecological cream containing collagen, phytocollagen, hyaluronate and vitamins was investigated in women in menopause. Methods: The cream was daily applied to the vaginal mucosa and the perineal skin as well as to the abdomi
Publikováno v:
Neurotoxicity Research. 23:315-326
Ralfinamide, an original Na(+) channel blocker developed for the treatment of chronic pain, inhibits monoamineoxidase-B with no apparent effect on monoamineoxidase-A. To evaluate the pressor response to oral tyramine under fasting conditions during t
Publikováno v:
Antimicrobial Agents and Chemotherapy. 55:2122-2128
The new oral 200-mg rifamycin SV MMX modified-release tablets, designed to deliver rifamycin SV directly into the colonic lumen, offer considerable advantages over the existing immediate-release antidiarrheic formulations. In two pharmacokinetics stu
Publikováno v:
European Journal of Clinical Pharmacology. 65:503-510
To assess the comparative pharmacokinetic profile and bioavailability of docosahexaenoic acid (DHA)/eicosapentaenoic acid (EPA) after multiple-dose administration of a new oral formulation (test formulation) and a commercially available reference for
Autor:
Giancarlo Tonon, Davide Crobu, Andrea F. D. Di Stefano, Domenica M. G. Lamparelli, Rodolfo Schrepfer, Gaia Spinetti, Jutta Michael Hepp, Antonio Rusca, Luca Loprete, Milko Radicioni
Publikováno v:
Clinical drug investigation. 35(9)
The new filgrastim formulation, BK0023, whose synthesis method is patented, was tested in a phase I clinical study that was aimed at investigating the pharmacodynamic and pharmacokinetic equivalence and the safety of BK0023 in healthy male subjects.
Autor:
Antonio Rusca, G. Celasco, Martin Brunner, Matthew Muller, Robert Dudczak, Pejman Dehghanyar, R. Villa, A. F. D. Di Stefano, S Ziegler, Kurt Kletter, R. Bozzella, Luigi Moro, M. Tschurlovits
Publikováno v:
British journal of clinical pharmacology. 61(1)
The aims of the study were to: (1) evaluate the gastrointestinal transit, release and absorption of budesonide from tablets with a new multimatrix formulation (MMX) designed to release the drug throughout the whole colon, and (2) assess the influence